Company · CIK 1835268
Connect Biopharma Holdings Ltd
| CIK | 1835268 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Business address | CA |
| Listed | CNTB (Nasdaq) |
| First annual or quarterly report | 2022-03-31 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-295921 | 2026-05-15 | 2026-06-01 | 2 | |
| 333-287918 | 2025-06-10 | 2025-09-12 | 3 | |
| 333-264340 | 2022-04-15 | 2022-07-06 | 2 | |
| 333-253631 | 2021-02-26 | 2021-03-19 | 6 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-06-01 | EFFECTDeclared effective | 333-295921 | 9999999995-26-001825 |
| 2026-05-15 | F-3Shelf registered | 333-295921 | 0001193125-26-225436 |
| 2025-09-12 | EFFECTDeclared effective | 333-287918 | 9999999995-25-002945 |
| 2025-06-26 | EFFECTDeclared effective | 333-287918 | 9999999995-25-002040 |
| 2025-06-10 | F-3Shelf registered | 333-287918 | 0001193125-25-138482 |
| 2022-07-06 | EFFECTDeclared effective | 333-264340 | 9999999995-22-001972 |
| 2022-04-15 | F-3Shelf registered | 333-264340 | 0001193125-22-106928 |
| 2021-03-19 | 424B4Final prospectus | 333-253631 | 0001193125-21-087643 |
| 2021-03-18 | EFFECTDeclared effective | 333-254215 | 9999999995-21-001011 |
| 2021-03-18 | EFFECTDeclared effective | 333-253631 | 9999999995-21-001006 |
| 2021-03-18 | F-1/AAmendment | 333-253631 | 0001193125-21-084781 |
| 2021-03-17 | F-1/AAmendment | 333-253631 | 0001193125-21-083442 |
| 2021-03-12 | F-1/AAmendment | 333-253631 | 0001193125-21-079813 |
| 2021-02-26 | F-1Registration filed | 333-253631 | 0001193125-21-060795 |
| 2020-12-17 | DRSDraft made public | 377-03905 | 0000950123-20-012706 |